These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Yttrium-90 microspheres (TheraSphere and SIR-Spheres) for the treatment of unresectable hepatocellular carcinoma. Allison C Issues Emerg Health Technol; 2007 Sep; (102):1-6. PubMed ID: 17824141 [TBL] [Abstract][Full Text] [Related]
7. Quality assurance issues for therapeutic application of radioactive microspheres. Dezarn WA Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S147-51. PubMed ID: 18406915 [TBL] [Abstract][Full Text] [Related]
8. Yttrium-90 radioembolization using TheraSphere in the management of primary and secondary liver tumors. Riaz A; Lewandowski RJ; Kulik L; Salem R Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):311-6. PubMed ID: 19521310 [TBL] [Abstract][Full Text] [Related]
9. [Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives]. Hilgard P; Müller S; Hamami M; Sauerwein WS; Haberkorn U; Gerken G; Antoch G Z Gastroenterol; 2009 Jan; 47(1):37-54. PubMed ID: 19156591 [TBL] [Abstract][Full Text] [Related]
10. Development of activity standard for 90 Y microspheres. Mo L; Avci B; James D; Simpson B; Van Wyngaardt WM; Cessna JT; Baldock C; Appl Radiat Isot; 2005 Aug; 63(2):193-9. PubMed ID: 15963429 [TBL] [Abstract][Full Text] [Related]
11. Temporary balloon occlusion of the common hepatic artery for administration of yttrium-90 resin microspheres in a patient with patent hepatoenteric collaterals. Mahvash A; Zaer N; Shaw C; Chasen B; Avritscher R; Murthy R J Vasc Interv Radiol; 2012 Feb; 23(2):277-80. PubMed ID: 22264555 [TBL] [Abstract][Full Text] [Related]
12. Severe coagulopathy after 90Y microsphere administration: resemblance to the Kasabach-Merritt syndrome. Hoffman MA; Rubin JI; Vinceguerra VP; Nowakowski FS; Warner RR J Vasc Interv Radiol; 2008 Jul; 19(7):1099-102. PubMed ID: 18589326 [No Abstract] [Full Text] [Related]
13. Preparation of ceramic microspheres for in situ radiotherapy of deep-seated cancer. Kawashita M; Shineha R; Kim HM; Kokubo T; Inoue Y; Araki N; Nagata Y; Hiraoka M; Sawada Y Biomaterials; 2003 Aug; 24(17):2955-63. PubMed ID: 12742735 [TBL] [Abstract][Full Text] [Related]
14. Superselective internal radiation with yttrium-90 microspheres in the management of a chemorefractory testicular liver metastasis. Sideras PA; Sofocleous CT; Brody LA; Siegelbaum RH; Shah RP; Taskar NP Cardiovasc Intervent Radiol; 2012 Apr; 35(2):426-9. PubMed ID: 21773859 [TBL] [Abstract][Full Text] [Related]
15. Prophylactic embolization of the gastroduodenal and right gastric arteries is not routinely necessary before radioembolization with glass microspheres. Hamoui N; Minocha J; Memon K; Sato K; Ryu R; Salem R; Lewandowski RJ J Vasc Interv Radiol; 2013 Nov; 24(11):1743-5. PubMed ID: 24160828 [No Abstract] [Full Text] [Related]
16. Radioembolization (yttrium-90 microspheres) for primary and metastatic hepatic malignancies. Kennedy AS; Salem R Cancer J; 2010; 16(2):163-75. PubMed ID: 20404614 [TBL] [Abstract][Full Text] [Related]
17. Preparation and properties of radioactive rhenium glass microspheres intended for in vivo radioembolization therapy. Conzone SD; Häfeli UO; Day DE; Ehrhardt GJ J Biomed Mater Res; 1998 Dec; 42(4):617-25. PubMed ID: 9827687 [TBL] [Abstract][Full Text] [Related]
18. (90)Y microspheres prepared by sol-gel method, promising medical material for radioembolization of liver malignancies. Łada W; Iller E; Wawszczak D; Konior M; Dziel T Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():629-635. PubMed ID: 27287162 [TBL] [Abstract][Full Text] [Related]
19. Radiation emission from patients treated with selective hepatic radioembolization using yttrium-90 microspheres: are contact restrictions necessary? McCann JW; Larkin AM; Martino LJ; Eschelman DJ; Gonsalves CF; Brown DB J Vasc Interv Radiol; 2012 May; 23(5):661-7. PubMed ID: 22440592 [TBL] [Abstract][Full Text] [Related]
20. Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe. Burgmans MC; Kao YH; Irani FG; Dames EL; Teo TK; Goh AS; Chow PK; Tay KH; Lo RH J Vasc Interv Radiol; 2012 Oct; 23(10):1294-301. PubMed ID: 22922039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]